Like parents everywhere, one of my greatest wishes for my child is good health. My wife and I have a son, Michael, a senior in college who just happens to have hemophilia, not to mention a great outlook on life. He enjoys a fairly active lifestyle, thanks in many ways to the outstanding research funded by the National Hemophilia Foundation. An expanded NHF research program will ensure that scientists have the funds needed to continue their research that will lead to improved therapies and one day, a cure. It is my honor and privilege to serve as Chairman of NHFs Leadership Council - a group of committed individuals who are passionate about raising funds to support research for hemophilia and other bleeding disorders, because research truly is our future. Thank you, Novo Nordisk and all our caring donors, for your dedication to the wellbeing of people with bleeding disorders. I am optimistic that others will follow your lead and make a gift of support to Research is Our Future. All gifts are greatly appreciated. Each and every gift makes a difference.
Richard Metz, M. D.
Chairman of NHF’s Leadership Council
Click to Donate!
Visionary Corporate Partner
and Lead Benefactor
Corporate Chair, CEO's Strategic Council
Novo Nordisk is proud to be the Visionary Corporate Partner and Lead Benefactor of the National Hemophilia Foundation’s Campaign for Our Future. As part of the company’s overall commitment to “changing possibilities in hemophilia,” this support is completely aligned with our values as a corporation. We believe so strongly in the vision of the Campaign that we worked with our peers in the industry to ensure that NHF had the support it needed to fulfill the Campaign’s vision.
Just recently, we made an additional investment to kick off Phase II of the Campaign, Research is Our Future. We are excited about what this means for hemophilia: dedicated resources to develop an aggressive research agenda, support for clinicians and researchers who tirelessly sacrifice more lucrative careers in return for lifelong service to people with bleeding disorders, and the promise of better treatments. I hope you will join us and consider supporting the campaign, which makes all of this possible.
Eddie Williams, Vice President
Biopharmaceutical Sales, Novo Nordisk